Xu_2024_Med.Microbiol.Immunol_213_16

Reference

Title : Repurposing promethazine hydrochloride to inhibit biofilm formation against Burkholderia thailandensis - Xu_2024_Med.Microbiol.Immunol_213_16
Author(s) : Xu KZ , You C , Wang YJ , Dar OI , Yin LJ , Xiang SL , Jia AQ
Ref : Med Microbiol Immunol , 213 :16 , 2024
Abstract :

Melioidosis is a severe infectious disease caused by Burkholderia pseudomallei, an intracellular pathogen with a high mortality rate and significant antibiotic resistance. The high mortality rate and resistance to antibiotics have drawn considerable attention from researchers studying melioidosis. This study evaluated the effects of various concentrations (75, 50, and 25 microg/mL) of promethazine hydrochloride (PTZ), a potent antihistamine, on biofilm formation and lipase activity after 24 h of exposure to B. thailandensis E264. A concentration-dependent decrease in both biofilm biomass and lipase activity was observed. RT-PCR analysis revealed that PTZ treatment not only made the biofilm structure loose but also reduced the expression of btaR1, btaR2, btaR3, and scmR. Single gene knockouts of quorum sensing (QS) receptor proteins (deltabtaR1, deltabtaR2, and deltabtaR3) were successfully constructed. Deletion of btaR1 affected biofilm formation in B. thailandensis, while deletion of btaR2 and btaR3 led to reduced lipase activity. Molecular docking and biological performance results demonstrated that PTZ inhibits biofilm formation and lipase activity by suppressing the expression of QS-regulated genes. This study found that repositioning PTZ reduced biofilm formation in B. thailandensis E264, suggesting a potential new approach for combating melioidosis.

PubMedSearch : Xu_2024_Med.Microbiol.Immunol_213_16
PubMedID: 39033094

Related information

Inhibitor Promethazine

Citations formats

Xu KZ, You C, Wang YJ, Dar OI, Yin LJ, Xiang SL, Jia AQ (2024)
Repurposing promethazine hydrochloride to inhibit biofilm formation against Burkholderia thailandensis
Med Microbiol Immunol 213 :16

Xu KZ, You C, Wang YJ, Dar OI, Yin LJ, Xiang SL, Jia AQ (2024)
Med Microbiol Immunol 213 :16